Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950123-10-076702
Filing Date
2010-08-12
Accepted
2010-08-12 16:34:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w79559be8vk.htm 425 15320
2 EX-99.1 w79559bexv99w1.htm EX-99.1 25799
3 GRAPHIC w79559bw7955902.gif GRAPHIC 2696
4 GRAPHIC w79559bw7955900.gif GRAPHIC 4232
  Complete submission text file 0000950123-10-076702.txt   52936
Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 2068380500
Trubion Pharmaceuticals, Inc (Subject) CIK: 0001298521 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33054 | Film No.: 101011540
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filed by) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations